Biotechnology is often hailed as the future of cosmetic formulations. Here,, Director and Cosmetic Chemist at the Institute ...

Fintel reports that on May 27, 2025, HC Wainwright & Co. downgraded their outlook for Unity Biotechnology (NasdaqGS:UBX) from ...

Sana Biotechnology, Inc.’s SANA share price has dipped by 5.61%, which has investors questioning if this is right time to buy.

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Vir Biotechnology, Inc. (NASDAQ:VIR) has already been able to initiate its late-stage ECLIPSE program, which is using the combination of monoclonal antibody tobevibart in combination with small ...

One company value investors might notice is Puma Biotechnology (PBYI). PBYI is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. PBYI is also sporting a PEG ratio of 1.38.

Too often, when people think of biotechnology and warfare, they remember headline-generating stories about biotechnology's misuse in the creation of new weapons of mass destruction. But lost among ...

Ivor Price is the co-founder and editor-in-chief of ‘Food For Mzansi’. He is the author of ‘For the Love of the Land’, a book that explores the deep connections between people, land, and ...

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical ...

Vir Biotechnology, Inc. (VIR) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.83. This compares to loss of $0.48 per share a year ago.